Polyrizon Ltd. (PLRZ) Financial Ratios
5 years of historical data (2020–2024) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
8.00
↓-97% vs avg
5yr avg: 306.98
ROE
↑
-57.8%
↓+98% vs avg
5yr avg: -3126.3%
30Y Low-456%·High-58%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PLRZ Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Polyrizon Ltd. trades at 28.3x earnings, 97% below its 5-year average of 1085.0x, sitting at the 50th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a premium of 27%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Market Cap | $59M | $1.6B | — | — | — | — |
| Enterprise Value | $57M | $1.6B | — | — | — | — |
| P/E Ratio → | 28.28 | 1085.00 | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — |
| P/B Ratio | 8.00 | 306.98 | — | — | — | — |
| P/FCF | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
PLRZ EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — |
PLRZ Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -57.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — |
| Net Profit Margin | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| ROE | -57.8% | -57.8% | -1052.6% | — | -10938.5% | -456.3% |
| ROA | -50.6% | -50.6% | -108.6% | -126.4% | -200.0% | -304.2% |
| ROIC | -65.4% | -65.4% | — | — | — | — |
| ROCE | -48.7% | -48.7% | -1114.0% | — | -10815.4% | -450.0% |
PLRZ Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $3M exceeds total debt of $0, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Debt / Equity | — | — | 3.51 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.48 | 3.44 | — | — | -0.63 |
| Net Debt / EBITDA | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — |
| Interest Coverage | -434.00 | -434.00 | -317.50 | -447.50 | -351.50 | — |
Net cash position: cash ($3M) exceeds total debt ($0)
PLRZ Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Polyrizon Ltd.'s current ratio of 10.16x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.04x to 10.16x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Current Ratio | 10.16 | 10.16 | 0.11 | 0.04 | 0.79 | 2.38 |
| Quick Ratio | 10.16 | 10.16 | 0.11 | 0.04 | 0.79 | 2.38 |
| Cash Ratio | 9.79 | 9.79 | 0.08 | 0.03 | 0.76 | 1.25 |
| Asset Turnover | — | — | — | — | — | — |
| Inventory Turnover | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — |
PLRZ Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Polyrizon Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 3.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Earnings Yield | 3.5% | 0.1% | — | — | — | — |
| FCF Yield | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $3M | $2M | $1M | $4M | $4M |
Peer Comparison
Compare PLRZ with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PLRZYou | $59M | 28.3 | — | — | — | — | -57.8% | -65.4% | — |
 SIGA | $339M | 14.3 | 7.6 | 7.0 | 68.6% | 25.1% | 11.2% | 33.7% | 0.0 |
 AGEN | $132M | -1102.9 | — | — | 90.3% | -18.0% | — | — | — |
 NVAX | $2B | 3.6 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 |
 NRXP | $85M | -2.3 | — | — | — | -1324.4% | — | — | — |
 PRPH | $5M | -0.0 | — | — | -2.2% | -570.6% | -188.1% | -59.4% | — |
 NNOX | $115M | -1.9 | — | — | -94.0% | -502.9% | -27.8% | -27.9% | — |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $277B | 15.4 | 10.7 | 22.4 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
 ABBV | $358B | 85.5 | 15.0 | 20.1 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 5 years · Updated daily
See PLRZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PLRZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PLRZ vs SIGA
Side-by-side business, growth, and profitability comparison vs SIGA Technologies, Inc..
Start ComparisonPLRZ — Frequently Asked Questions
Quick answers to the most common questions about buying PLRZ stock.
What is Polyrizon Ltd.'s P/E ratio?
Polyrizon Ltd.'s current P/E ratio is 28.3x. This places it at the 50th percentile of its historical range.
What is Polyrizon Ltd.'s ROE?
Polyrizon Ltd.'s return on equity (ROE) is -57.8%. The historical average is -257.0%.
Is PLRZ stock overvalued?
Based on historical data, Polyrizon Ltd. is trading at a P/E of 28.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.